Funding for this research was provided by:
Seipel Group, Brisbane, Australia (NA)
Received: 6 December 2016
Accepted: 17 January 2018
First Online: 31 January 2018
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of Endeavour College of Natural Health (Queensland, Australia). All participants provided written informed consent.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure atExternalRef removedand declare: TS is the inventor of the US patent, Herbal Compositions For The Prevention Or Treatment Of Urinary Incontinence And Overactive Bladder, U.S. Patent Number No. 9,452,191, for the formulation assessed in the trial. Seipel Group provided funding and materials for this study, and employs TS.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.